Allicin Based Inhibition Of Eryptosis: A Novel Therapeutic Approach Against Hyperosmolarity Triggered Anemia

Read full text Summarise with VIRAT
Authors: Maham Abdul Bari Khan, Kashif Jilani, Zahid Mushtaq, Haq Nawaz
Cited by: 0
References: 51

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Hyperosmotic stress is often overlooked in various clinical conditions like diabetes and may lead to anemia. Erythrocytes are very sensitive cells in body circulation and are affected by very minute changes in the environment. Eryptosis (suicidal death of erythrocytes) is mainly characterized by phosphatidylserine exposure, cell shrinkage, blabbing and is triggered by hyperosmolarity, oxidative stress, energy depletion, xenobiotic exposure and activation of various kinases. Objective: This study was planned to evaluate the eryptotic effects of hyperosmolarity by stimulating p38 MAPK and enhanced ROS generation and allicin’s anti-hemolytic, antioxidant, p38MAPK inhibitory and anti-eryptotic potential. Methods: Effects of allicin on erythrocytes facing hyperosmolarity were confirmed by measuring enzyme activity (SOD, GPx and CAT), ROS level, eryptotic marker (change in cell size and phosphatidylserine exposure) and underlying mechanisms of eryptosis (role of Ca2+ in eryptosis and p38 MAPK activation) were confirmed. To measure the cytotoxic effects of allicin hemolysis % was measured. To check statistical significance of data ANOVA was used. Results: Results confirmed that allicin treatment enhances SOD, GPx and CAT activity, reduces ROS level, p38 MAPK activation and Ca2+ effects, positively affects cell size (normal range) and phosphatidylserine exposure (reduced) and reduces hemolysis % in erythrocytes facing hyperosmolarity. Conclusion: It is concluded from this study that hyperosmolarity is the main stimulator of eryptosis and leads to anemia in various clinical conditions, while allicin treatment helps to increase erythrocyte survival by inhibiting and attenuating various pathways and reducing eryptpotic rate. Allicin’s anti-eryptotic and cytoprotective potential gives foundation for future clinical research targeting hyperosmolarity triggered anemia.

Fields of Study & Subjects

Erythrocyte Function and Pathophysiology Garlic and Onion Studies Blood properties and coagulation

Publication details

Journal / source
Pakistan Journal of Pharmaceutical Sciences
Volume
39
Issue
5
Pages
1413–1422
Publication date
8 March 2026
Language
EN